AKT1 and liver cancer: Next, we tested the hypothesis that concomitant deletion of Yap and Taz would significantly suppress Akt/NRas-driven hepatocarcinogenesis by using Yap;Taz double KO mice in the Akt/NRas mouse liver cancer model.